{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:31:08Z","timestamp":1794429068029,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s40123-023-00730-z","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T23:27:42Z","timestamp":1686698862000},"page":"2227-2240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Adherence and Persistence to Medical Therapy in Glaucoma: An Overview"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-1713","authenticated-orcid":false,"given":"Luciano","family":"Quaranta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Novella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pasina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"issue":"6","key":"730_CR1","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.survophthal.2008.08.002","volume":"53","author":"GF Schwartz","year":"2008","unstructured":"Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(6):S57-68.","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"730_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1185\/03007995.2013.818968","volume":"29","author":"RG Alany","year":"2013","unstructured":"Alany RG. Adherence, persistence and cost\u2013consequence comparison of bimatoprost topical ocular formulations. Curr Med Res Opin. 2013;29(9):1187\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"730_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/mcp.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304\u201314.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"730_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40273-017-0570-9","volume":"36","author":"A Monnette","year":"2018","unstructured":"Monnette A, Zhang Y, Shao H, Shi L. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices: an updated review. Pharmacoeconomics. 2018;36(1):17\u201327.","journal-title":"Pharmacoeconomics"},{"key":"730_CR5","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S19801","author":"M McGuire","year":"2014","unstructured":"McGuire M, Iuga. Adherence and health care costs. RMHP. 2014. https:\/\/doi.org\/10.2147\/RMHP.S19801.","journal-title":"RMHP"},{"issue":"1","key":"730_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1586\/17469899.2016.1134318","volume":"11","author":"PA Newman-Casey","year":"2016","unstructured":"Newman-Casey PA, Dayno M, Robin AL. Systematic review of educational interventions to improve glaucoma medication adherence: an update in 2015. Expert Rev Ophthalmol. 2016;11(1):5\u201320.","journal-title":"Expert Rev Ophthalmol"},{"issue":"7","key":"730_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0301-4738.73693","volume":"59","author":"A Robin","year":"2011","unstructured":"Robin A, Grover D. Compliance and adherence in glaucoma management. Indian J Ophthalmol. 2011;59(7):93.","journal-title":"Indian J Ophthalmol"},{"key":"730_CR8","doi-asserted-by":"crossref","unstructured":"Waterman H, Evans JR, Gray TA, Henson D, Harper R. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Eyes and Vision Group, editor. Cochrane Database Syst Rev [Internet]. 2013 [cited 2023 Jan 30]; https:\/\/doi.wiley.com\/10.1002\/14651858.CD006132.pub3","DOI":"10.1002\/14651858.CD006132.pub3"},{"issue":"6","key":"730_CR9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1442-9071.2009.02101.x","volume":"37","author":"X Chen","year":"2009","unstructured":"Chen X, Chen Y, Sun X. Notable role of glaucoma club on patients\u2019 knowledge of glaucoma. Clin Exp Ophthalmol. 2009;37(6):590\u20134.","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"730_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/IJG.0b013e3182127a9b","volume":"21","author":"P Blondeau","year":"2012","unstructured":"Blondeau P, Carbonneau M, Esper P, Turcotte PC. A 2-hour information session and patient recall has minimal impact on glaucoma-treatment persistence in a mature practice. J Glaucoma. 2012;21(6):379\u201382.","journal-title":"J Glaucoma"},{"issue":"12","key":"730_CR11","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.ophtha.2009.05.026","volume":"116","author":"CO Okeke","year":"2009","unstructured":"Okeke CO, Quigley HA, Jampel HD, Ying G, Plyler RJ, Jiang Y, et\u00a0al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116(12):2286\u201393.","journal-title":"Ophthalmology"},{"issue":"6197","key":"730_CR12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1136\/bmj.2.6197.1031","volume":"2","author":"SE Norell","year":"1979","unstructured":"Norell SE. Improving medication compliance: a randomised clinical trial. Br Med J. 1979;2(6197):1031\u20133.","journal-title":"Br Med J"},{"issue":"11","key":"730_CR13","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1167\/iovs.07-0290","volume":"48","author":"DS Friedman","year":"2007","unstructured":"Friedman DS, Quigley HA, Gelb L, Tan J, Margolis J, Shah SN, et\u00a0al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48(11):5052\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"730_CR14","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.ophtha.2007.11.023","volume":"115","author":"DS Friedman","year":"2008","unstructured":"Friedman DS, Hahn SR, Gelb L, Tan J, Shah SN, Kim EE, et\u00a0al. Doctor\u2013patient communication, health-related beliefs, and adherence in glaucoma. Ophthalmology. 2008;115(8):1320-1327.e3.","journal-title":"Ophthalmology"},{"issue":"4","key":"730_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10792-010-9362-3","volume":"30","author":"MM Hermann","year":"2010","unstructured":"Hermann MM, Ust\u00fcndag C, Diestelhorst M. Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol. 2010;30(4):385\u201390.","journal-title":"Int Ophthalmol"},{"issue":"5","key":"730_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0002-9394(86)90939-6","volume":"101","author":"MA Kass","year":"1986","unstructured":"Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101(5):515\u201323.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"730_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67\u201374.","journal-title":"Med Care"},{"key":"730_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2147\/PPA.S176412","volume":"13","author":"JF McClelland","year":"2019","unstructured":"McClelland JF, Bodle L, Little JA. Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes. Patient Prefer Adherence. 2019;13:431\u20139.","journal-title":"Patient Prefer Adherence"},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2018.01.011","volume":"188","author":"KH Na","year":"2018","unstructured":"Na KH, Yoo C, Park JH, Kim YY. Eye drop dispenser type and medication possession ratio in patients with glaucoma: single-use containers versus multiple-use bottles. Am J Ophthalmol. 2018;188:9\u201318.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"730_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40273-017-0597-y","volume":"36","author":"MV Bjarnadottir","year":"2018","unstructured":"Bjarnadottir MV, Czerwinski D, Onukwugha E. Sensitivity of the medication possession ratio to modelling decisions in large claims databases. Pharmacoeconomics. 2018;36(3):369\u201380.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"730_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/jcm5090079","volume":"5","author":"M Feehan","year":"2016","unstructured":"Feehan M, Munger M, Cooper D, Hess K, Durante R, Jones G, et\u00a0al. Adherence to glaucoma medications over 12 months in two US community pharmacy chains. JCM. 2016;5(9):79.","journal-title":"JCM"},{"issue":"5","key":"730_CR22","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/0002-9394(74)90299-2","volume":"78","author":"RD Yee","year":"1974","unstructured":"Yee RD, Hahn PM, Christensen RE. Medication monitor for ophthalmology. Am J Ophthalmol. 1974;78(5):774\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"730_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bjo.66.7.464","volume":"66","author":"PA Granstr\u00f6m","year":"1982","unstructured":"Granstr\u00f6m PA. Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects. Br J Ophthalmol. 1982;66(7):464\u201370.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"730_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0002-9394(14)74670-7","volume":"92","author":"SE Norell","year":"1981","unstructured":"Norell SE. Monitoring compliance with pilocarpine therapy. Am J Ophthalmol. 1981;92(5):727\u201331.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"730_CR25","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/bjo.2005.088526","volume":"90","author":"MM Hermann","year":"2006","unstructured":"Hermann MM, Diestelhorst M. Microprocessor controlled compliance monitor for eye drop medication. Br J Ophthalmol. 2006;90(7):830\u20132.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"730_CR26","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1097\/IJG.0000000000000777","volume":"26","author":"JD Gatwood","year":"2017","unstructured":"Gatwood JD, Johnson J, Jerkins B. Comparisons of self-reported glaucoma medication adherence with a new wireless device: a pilot study. J Glaucoma. 2017;26(11):1056\u201361.","journal-title":"J Glaucoma"},{"issue":"5","key":"730_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00061198-200310000-00001","volume":"12","author":"JC Tsai","year":"2003","unstructured":"Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12(5):393\u20138.","journal-title":"J Glaucoma"},{"issue":"Pt 5","key":"730_CR28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/eye.2000.197","volume":"14","author":"AG Konstas","year":"2000","unstructured":"Konstas AG, Maskaleris G, Gratsonidis S, Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye (Lond). 2000;14(Pt 5):752\u20136.","journal-title":"Eye (Lond)"},{"issue":"8","key":"730_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/IJG.0b013e31816b3001","volume":"17","author":"L Gelb","year":"2008","unstructured":"Gelb L, Friedman DS, Quigley HA, Lyon DW, Tan J, Kim EE, et\u00a0al. Physician beliefs and behaviors related to glaucoma treatment adherence: the glaucoma adherence and persistency study. J Glaucoma. 2008;17(8):690\u20138.","journal-title":"J Glaucoma"},{"issue":"7","key":"730_CR30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/archinte.1990.00390190043003","volume":"150","author":"AR Feinstein","year":"1990","unstructured":"Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150(7):1377\u20138.","journal-title":"Arch Intern Med"},{"issue":"4","key":"730_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ophtha.2006.09.025","volume":"114","author":"GF Schwartz","year":"2007","unstructured":"Schwartz GF, Platt R, Reardon G, Mychaskiw MA. Accounting for restart rates in evaluating persistence with ocular hypotensives. Ophthalmology. 2007;114(4):648\u201352.","journal-title":"Ophthalmology"},{"issue":"8","key":"730_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/bjo.74.8.477","volume":"74","author":"AJ Winfield","year":"1990","unstructured":"Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol. 1990;74(8):477\u201380.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"730_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ophtha.2005.10.034","volume":"113","author":"B Sleath","year":"2006","unstructured":"Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113(3):431\u20136.","journal-title":"Ophthalmology"},{"issue":"10","key":"730_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-2008-1035132","volume":"211","author":"S Busche","year":"1997","unstructured":"Busche S, Gramer E. Verbesserung der Augentropfenapplikation und Compliance bei Glaukompatienten\u2014Eine klinische Studie. Klin Monatsbl Augenheilkd. 1997;211(10):257\u201362.","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"5","key":"730_CR35","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ophtha.2004.12.026","volume":"112","author":"AL Robin","year":"2005","unstructured":"Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112(5):863\u20138.","journal-title":"Ophthalmology"},{"issue":"8","key":"730_CR36","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","volume":"23","author":"AJ Claxton","year":"2001","unstructured":"Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296\u2013310.","journal-title":"Clin Ther"},{"issue":"10 Suppl","key":"730_CR37","first-page":"S255","volume":"8","author":"S Dasgupta","year":"2002","unstructured":"Dasgupta S, Oates V, Bookhart BK, Vaziri B, Schwartz GF, Mozaffari E. Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data. Am J Manag Care. 2002;8(10 Suppl):S255-261.","journal-title":"Am J Manag Care"},{"issue":"Suppl 4","key":"730_CR38","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1177\/112067210301304S03","volume":"13","author":"M Diestelhorst","year":"2003","unstructured":"Diestelhorst M, Schaefer CP, Beusterien KM, Plante KM, Fain JM, Mozaffari E, et\u00a0al. Persistency and clinical outcomes associated with latanoprost and beta-blocker monotherapy: evidence from a European retrospective cohort study. Eur J Ophthalmol. 2003;13(Suppl 4):S21-29.","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"730_CR39","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","volume":"140","author":"BL Nordstrom","year":"2005","unstructured":"Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140(4):598\u2013606.","journal-title":"Am J Ophthalmol"},{"issue":"4_suppl","key":"730_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/112067210301304S05","volume":"13","author":"G Reardon","year":"2003","unstructured":"Reardon G, Schwartz GF, Mozaffari E. Patient persistency with pharmacotherapy in the management of glaucoma. Eur J Ophthalmol. 2003;13(4_suppl):44\u201352.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"730_CR41","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.ajo.2003.10.034","volume":"137","author":"GF Schwartz","year":"2004","unstructured":"Schwartz GF, Reardon G, Mozaffari E. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Ophthalmol. 2004;137(1):S13\u20136.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"730_CR42","first-page":"233","volume":"26","author":"SC Patel","year":"1995","unstructured":"Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995;26(3):233\u20136.","journal-title":"Ophthalmic Surg"},{"issue":"7","key":"730_CR43","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.ophtha.2013.01.002","volume":"120","author":"DS Chang","year":"2013","unstructured":"Chang DS, Friedman DS, Frazier T, Plyler R, Boland MV. Development and validation of a predictive model for nonadherence with once-daily glaucoma medications. Ophthalmology. 2013;120(7):1396\u2013402.","journal-title":"Ophthalmology"},{"issue":"1","key":"730_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mds.870130105","volume":"13","author":"ED Louis","year":"1998","unstructured":"Louis ED, Ottman R, Allen HW. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord. 1998;13(1):5\u201310.","journal-title":"Mov Disord"},{"issue":"4","key":"730_CR45","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/eye.2008.103","volume":"23","author":"J Lacey","year":"2009","unstructured":"Lacey J, Cate H, Broadway DC. Barriers to adherence with glaucoma medications: a qualitative research study. Eye (Lond). 2009;23(4):924\u201332.","journal-title":"Eye (Lond)"},{"issue":"11","key":"730_CR46","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.ophtha.2009.06.024","volume":"116","author":"JC Tsai","year":"2009","unstructured":"Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11):S30\u20136.","journal-title":"Ophthalmology"},{"issue":"6","key":"730_CR47","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"730_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191185","volume":"13","author":"S Frech","year":"2018","unstructured":"Frech S, Kreft D, Guthoff RF, Doblhammer G. Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients\u2014an observational cohort study. PLoS ONE. 2018;13(1): e0191185.","journal-title":"PLoS ONE"},{"key":"730_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/479596","volume":"2014","author":"A Alhewiti","year":"2014","unstructured":"Alhewiti A. Adherence to long-term therapies and beliefs about medications. Int J Family Med. 2014;2014: 479596.","journal-title":"Int J Family Med"},{"issue":"9","key":"730_CR50","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ophtha.2005.02.030","volume":"112","author":"DS Friedman","year":"2005","unstructured":"Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology. 2005;112(9):1500\u20134.","journal-title":"Ophthalmology"},{"issue":"3","key":"730_CR51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00005650-199803000-00012","volume":"36","author":"JH Gurwitz","year":"1998","unstructured":"Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J. Patient noncompliance in the managed care setting: the case of medical therapy for glaucoma. Med Care. 1998;36(3):357\u201369.","journal-title":"Med Care"},{"issue":"11","key":"730_CR52","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0161-6420(98)91134-4","volume":"105","author":"O Kosoko","year":"1998","unstructured":"Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents\u2019 eye clinic. Ophthalmology. 1998;105(11):2105\u201311.","journal-title":"Ophthalmology"},{"issue":"4","key":"730_CR53","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ajo.2006.11.036","volume":"143","author":"DS Friedman","year":"2007","unstructured":"Friedman DS, Jampel HD, Congdon NG, Miller R, Quigley HA. The TRAVATAN dosing aid accurately records when drops are taken. Am J Ophthalmol. 2007;143(4):699\u2013701.","journal-title":"Am J Ophthalmol"},{"key":"730_CR54","doi-asserted-by":"crossref","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options. Br J Ophthalmol. 2017;101(6):130\u201395.","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.003"},{"issue":"1","key":"730_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/02713683.2014.1002045","volume":"41","author":"LE Dreer","year":"2016","unstructured":"Dreer LE, Owsley C, Campbell L, Gao L, Wood A, Girkin CA. Feasibility, patient acceptability, and preliminary efficacy of a culturally informed, health promotion program to improve glaucoma medication adherence among African Americans: \u201c Glaucoma Management Optimism for African Americans Living with Glaucoma\u201d (GOAL). Curr Eye Res. 2016;41(1):50\u20138.","journal-title":"Curr Eye Res"},{"key":"730_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1683430","volume":"2017","author":"TM Atey","year":"2017","unstructured":"Atey TM, Shibeshi W, Giorgis AT, Asgedom SW. The impact of adherence and instillation proficiency of topical glaucoma medications on intraocular pressure. J Ophthalmol. 2017;2017:1\u20138.","journal-title":"J Ophthalmol"},{"issue":"3","key":"730_CR57","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.survophthal.2016.12.009","volume":"62","author":"I Davies","year":"2017","unstructured":"Davies I, Williams AM, Muir KW. Aids for eye drop administration. Surv Ophthalmol. 2017;62(3):332\u201345.","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"730_CR58","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40258-019-00497-0","volume":"17","author":"M Bilger","year":"2019","unstructured":"Bilger M, Wong TT, Lee JY, Howard KL, Bundoc FG, Lamoureux EL, et\u00a0al. Using adherence-contingent rebates on chronic disease treatment costs to promote medication adherence: results from a randomized controlled trial. Appl Health Econ Health Policy. 2019;17(6):841\u201355.","journal-title":"Appl Health Econ Health Policy"},{"issue":"5","key":"730_CR59","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/10807680260362687","volume":"18","author":"SA Taylor","year":"2002","unstructured":"Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther. 2002;18(5):401\u20139.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"730_CR60","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13063-016-1459-1","volume":"17","author":"M Bilger","year":"2016","unstructured":"Bilger M, Wong TT, Howard KL, Lee JY, Toh AN, John G, et\u00a0al. Study on Incentives for Glaucoma Medication Adherence (SIGMA): study protocol for a randomized controlled trial to increase glaucoma medication adherence using value pricing. Trials. 2016;17(1):316.","journal-title":"Trials"},{"issue":"4","key":"730_CR61","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/14740338.2021.1873947","volume":"20","author":"AG Konstas","year":"2021","unstructured":"Konstas AG, Labb\u00e9 A, Katsanos A, Meier-Gibbons F, Irkec M, Boboridis KG, et\u00a0al. The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability. Expert Opin Drug Saf. 2021;20(4):453\u201366.","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"730_CR62","first-page":"2089","volume":"71","author":"FJ Domino","year":"2005","unstructured":"Domino FJ. Improving adherence to treatment for hypertension. Am Fam Physician. 2005;71(11):2089\u201390.","journal-title":"Am Fam Physician"},{"issue":"12","key":"730_CR63","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2165\/00002512-200421120-00004","volume":"21","author":"CM Hughes","year":"2004","unstructured":"Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging. 2004;21(12):793\u2013811.","journal-title":"Drugs Aging"},{"issue":"3","key":"730_CR64","first-page":"396","volume":"13","author":"DA Sclar","year":"1991","unstructured":"Sclar DA, Skaer TL, Chin A, Okamoto MP, Nakahiro RK, Gill MA. Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma. Clin Ther. 1991;13(3):396\u2013400.","journal-title":"Clin Ther"},{"key":"730_CR65","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S82909","author":"G Vakros","year":"2015","unstructured":"Vakros G, McVeigh K. The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clin Ophthalmol. 2015. https:\/\/doi.org\/10.2147\/OPTH.S82909.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"730_CR66","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1586\/17434440.4.2.261","volume":"4","author":"MY Kahook","year":"2007","unstructured":"Kahook MY. Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectives. Expert Rev Med Devices. 2007;4(2):261\u20136.","journal-title":"Expert Rev Med Devices"},{"issue":"11","key":"730_CR67","first-page":"654","volume":"67","author":"SF Laster","year":"1996","unstructured":"Laster SF, Martin JL, Fleming JB. The effect of a medication alarm device on patient compliance with topical pilocarpine. J Am Optom Assoc. 1996;67(11):654\u20138.","journal-title":"J Am Optom Assoc"},{"issue":"1","key":"730_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2415-8-9","volume":"8","author":"E Koshy","year":"2008","unstructured":"Koshy E, Car J, Majeed A. Effectiveness of mobile-phone short message service (SMS) reminders for ophthalmology outpatient appointments: observational study. BMC Ophthalmol. 2008;8(1):9.","journal-title":"BMC Ophthalmol"},{"issue":"9","key":"730_CR69","doi-asserted-by":"publisher","first-page":"e787","DOI":"10.1097\/IJG.0000000000000504","volume":"25","author":"M Waisbourd","year":"2016","unstructured":"Waisbourd M, Dhami H, Zhou C, Hsieh M, Abichandani P, Pro MJ, et\u00a0al. The wills eye glaucoma app: interest of patients and their caregivers in a smartphone-based and tablet-based glaucoma application. J Glaucoma. 2016;25(9):e787\u201391.","journal-title":"J Glaucoma"},{"key":"730_CR70","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajo.2016.11.020","volume":"175","author":"RA Lewis","year":"2017","unstructured":"Lewis RA, Christie WC, Day DG, Craven ER, Walters T, Bejanian M, et\u00a0al. Bimatoprost sustained-release implants for glaucoma therapy: 6-month results from a phase I\/II clinical trial. Am J Ophthalmol. 2017;175:137\u201347.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"730_CR71","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/jop.2018.0067","volume":"35","author":"JR Seal","year":"2019","unstructured":"Seal JR, Robinson MR, Burke J, Bejanian M, Coote M, Attar M. Intracameral sustained-release bimatoprost implant delivers bimatoprost to target tissues with reduced drug exposure to off-target tissues. J Ocul Pharmacol Ther. 2019;35(1):50\u20137.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"730_CR72","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.ophtha.2017.04.022","volume":"124","author":"JD Brandt","year":"2017","unstructured":"Brandt JD, DuBiner HB, Benza R, Sall KN, Walker GA, Semba CP, et\u00a0al. Long-term safety and efficacy of a sustained-release bimatoprost ocular ring. Ophthalmology. 2017;124(10):1565\u20136.","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-023-00730-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T07:21:40Z","timestamp":1692602500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-023-00730-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1007\/s40123-023-00730-z","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}